Sittner & Nelson’s Cantel Medical Corporation CMD Stock Holding History

Sittner & Nelson’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-52	Closed	-$4K	–	459
2020 Q4	$4K	Buy	+52	New	+$3.05K	﹤0.01%	351

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sittner & Nelson's CMD Position: Q1 2021 in Review

Sittner & Nelson sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 52 shares — an estimated $4K sold.

Sittner & Nelson first reported a position in CMD in Q4 2020 and held it in 1 quarter. The position peaked at $4K in Q4 2020. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

Sittner & Nelson reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
Sittner & Nelson sold 52 Cantel Medical Corporation shares in Q1 2021, an estimated $4K.
Sittner & Nelson first reported a position in Cantel Medical Corporation in Q4 2020 and held it in 1 quarter.
Sittner & Nelson's Cantel Medical Corporation position peaked at $4K in Q4 2020.
234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Sittner & Nelson's 13F filing for Q1 2021, filed 6 May 2021.